2370 logo

MEDINET Co., Ltd. Stock Price

TSE:2370 Community·JP¥8.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

2370 Share Price Performance

JP¥32.00
-3.00 (-8.57%)
JP¥32.00
-3.00 (-8.57%)
Price JP¥32.00

2370 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

MEDINET Co., Ltd. Key Details

JP¥998.0m

Revenue

JP¥668.0m

Cost of Revenue

JP¥330.0m

Gross Profit

JP¥3.4b

Other Expenses

-JP¥3.0b

Earnings

Last Reported Earnings
Sep 30, 2018
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About 2370

Founded
1995
Employees
n/a
CEO
Kanenao Kubushiro
WebsiteView website
www.medinet-inc.co.jp

MEDINET Co., Ltd. operates as a contract development and manufacturing organization that provides regenerative medicine and cell therapy solutions in Japan. It operates through two segments: Cell Processing Business and Regenerative Medicine Products Business.The company’s solutions include technical know-how, facilities, systems, materials, professional cell-engineers, and other requirements to conduct immuno-cell therapy.It also manufactures regenerative medical/investigational and specified cell products. In addition, the company offers value chain solutions, such as personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management system, quality control and assurance, and technology transfer and process development solutions. The company serves medical institutions, research institutions, and biopharmaceutical companies. MEDINET Co., Ltd. was incorporated in 1995 and is headquartered in Tokyo, Japan.

Recent 2370 News & Updates

Recent updates

No updates